Received: 6 May 2021
Revised: 1 December 2021
Accepted: 15 December 2021
First Online: 24 January 2022
: Dr. Kramer is a consultant for Bayer pharmaceuticals. The other authors have no financial disclosures of conflict of interest
Free to read: This content has been made available to all.